Recent MSK Discoveries & Advances

Our Research Impact
Paul Marks Prize for Cancer Research
Recent MSK Discoveries & Advances
Research Awards & Honors
Researcher Interviews
Emeritus Faculty

Recent MSK Discoveries & Advances

Share
Share

Memorial Sloan Kettering researchers are relentlessly exploring every aspect of cancer — from basic investigations of cells and molecules to clinical trials of new treatments and population-wide studies of the disease. While our core mission is to translate this knowledge into new strategies to control cancer, many of our investigators are also making scientific progress against other diseases and conditions.

Below are some examples of discoveries and advances that recently were made in our laboratories and clinics, and featured in our news stories.

and/or
375 News Items found
In the Lab
An organoid of a developing brain
Stem Cell Research Identifies Potential Drugs for Treating Zika Infection

Researchers from MSK and Weill Cornell have found that two compounds appear to fight off infection with the Zika virus.
In the Lab
A scientist looks at illustrations of chromosomes.
When Loss Is a Gain: New Tumor Suppressor Gene Identified in Follicular Lymphoma

The reason certain patients with follicular lymphoma do worse than others may come down to a missing gene.
Caregiving
Female caregiver helping older man with groceries
Signs of Depression Associated with Physical Health Decline among Cancer Caregivers

Learn how depression and caregiver health are linked.
In the Lab
Images from three different mice showing the effects of antibiotics and microbiome replacement
Bacteria versus Bacteria: Two Studies Uncover Species of Microbes That Protect against Infections in People with Cancer

Research recently published by MSK scientists suggests that the best way to fight dangerous bacteria may be with other bacteria.
Science Byte
Developmental biologist Anna-Katerina (Kat) Hadjantonakis
It Takes Two: A Pair of Proteins Coordinate to Direct Development of Embryonic Cells

MSK researchers shed light on the signals that determine the fate of embryonic cells.
In the Clinic
MSK medical oncologist Luis Diaz, Jr.
The Science Behind the FDA’s Approval of an Immunotherapy for Mismatch Repair–Deficient Cancers

A new paper from MSK physician-scientist Luis Diaz presents the evidence on which the FDA approved the immunotherapy drug pembrolizumab for cancers with a specific genetic abnormality.
Finding
Lymph nodes and lymphatic vessels with adjacent blood vessels
Definitive Study Shows That People with Melanoma Do Not Need Immediate Lymph Node Removal

The results of a large, international randomized trial herald a change in medical practice for the treatment of melanoma.
In the News
American Society of Clinical Oncology logo
#ASCO17: Post-Conference Roundup of Themes and Trends

Read up on the progress being made in several key areas of cancer research, including immunotherapy, targeted therapy, precision surgery, and epigenetics.
In the Clinic
Head shot of doctor with glasses, white shirt, and blue tie in his lab.
Drug Reduces Recurrence Risk in Subset of Women with Breast Cancer

A drug was shown to improve outcomes in women with HER2-positive early breast cancer when added to standard therapy.
In the Clinic
Ethan Basch
Online Symptom-Monitoring Tool Improves Survival for Those Undergoing Chemotherapy for Metastatic Cancer

A study presented at the 2017 annual meeting of the American Society of Clinical Oncology showed that an online tool to monitor patients’ symptoms improved overall survival.